Cardiocast

Societies refresh diabetes and PAD guidance


 

This week, the barbershop may become a key battleground in the fight against hypertension, the American Diabetes Association upgrades newer antihyperglycemics, refreshed appropriate use criteria for peripheral artery disease are released, and body mass index as a measure of cardiometabolic risk gets a boost.

Subscribe to Cardiocast wherever you get your podcasts.

Amazon Alexa

Apple Podcasts

Recommended Reading

FOURIER analysis: PCSK9 inhibition helps MetS patients the most
Type 2 Diabetes ICYMI
ASCEND: Aspirin, fish oil flop in diabetes
Type 2 Diabetes ICYMI
Statins aren’t preventive in elderly unless they have diabetes
Type 2 Diabetes ICYMI
Fish oil phoenix
Type 2 Diabetes ICYMI
Canagliflozin approved for cardiovascular event risk reduction
Type 2 Diabetes ICYMI
Sleep: The new frontier in cardiovascular prevention
Type 2 Diabetes ICYMI
DECLARE: Dapagliflozin improves some cardiovascular, renal outcomes
Type 2 Diabetes ICYMI
Empagliflozin reduces left ventricular mass
Type 2 Diabetes ICYMI
CAC scores in type 1 diabetes no higher than general population
Type 2 Diabetes ICYMI
CABG surpasses PCI for diabetics out to 7.5 years
Type 2 Diabetes ICYMI